Logo image of MYNA

MYNARIC AG NA O.N. (MYNA) Stock Fundamental Analysis

NASDAQ:MYNA - Nasdaq - US62857X1019 - ADR - Currency: USD

0.2628  -0.16 (-38.02%)

After market: 0.2498 -0.01 (-4.95%)

Fundamental Rating

2

Overall MYNA gets a fundamental rating of 2 out of 10. We evaluated MYNA against 65 industry peers in the Aerospace & Defense industry. MYNA may be in some trouble as it scores bad on both profitability and health. MYNA is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year MYNA has reported negative net income.
In the past year MYNA has reported a negative cash flow from operations.
In the past 5 years MYNA always reported negative net income.
MYNA had a negative operating cash flow in each of the past 5 years.
MYNA Yearly Net Income VS EBIT VS OCF VS FCFMYNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20M -40M -60M -80M

1.2 Ratios

MYNA's Return On Assets of -78.54% is on the low side compared to the rest of the industry. MYNA is outperformed by 87.50% of its industry peers.
Industry RankSector Rank
ROA -78.54%
ROE N/A
ROIC N/A
ROA(3y)-70.83%
ROA(5y)-51.71%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MYNA Yearly ROA, ROE, ROICMYNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600

1.3 Margins

MYNA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MYNA Yearly Profit, Operating, Gross MarginsMYNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -1K -2K -3K

More info and screens

0

2. Health

2.1 Basic Checks

MYNA does not have a ROIC to compare to the WACC, probably because it is not profitable.
MYNA has more shares outstanding than it did 1 year ago.
MYNA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for MYNA is higher compared to a year ago.
MYNA Yearly Shares OutstandingMYNA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
MYNA Yearly Total Debt VS Total AssetsMYNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

MYNA has an Altman-Z score of -5.29. This is a bad value and indicates that MYNA is not financially healthy and even has some risk of bankruptcy.
MYNA has a Altman-Z score of -5.29. This is amonst the worse of the industry: MYNA underperforms 90.63% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.29
ROIC/WACCN/A
WACC17.03%
MYNA Yearly LT Debt VS Equity VS FCFMYNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M

2.3 Liquidity

MYNA has a Current Ratio of 0.74. This is a bad value and indicates that MYNA is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of MYNA (0.74) is worse than 90.63% of its industry peers.
A Quick Ratio of 0.44 indicates that MYNA may have some problems paying its short term obligations.
MYNA has a Quick ratio of 0.44. This is amonst the worse of the industry: MYNA underperforms 92.19% of its industry peers.
Industry RankSector Rank
Current Ratio 0.74
Quick Ratio 0.44
MYNA Yearly Current Assets VS Current LiabilitesMYNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

More info and screens

7

3. Growth

3.1 Past

MYNA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.02%.
The Revenue has grown by 21.89% in the past year. This is a very strong growth!
MYNA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 31.63% yearly.
EPS 1Y (TTM)-14.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-34.86%
Revenue 1Y (TTM)21.89%
Revenue growth 3Y99.48%
Revenue growth 5Y31.63%
Sales Q2Q%-78.12%

3.2 Future

The Earnings Per Share is expected to grow by 18.85% on average over the next years. This is quite good.
MYNA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 72.08% yearly.
EPS Next Y11.27%
EPS Next 2Y15.74%
EPS Next 3Y18.85%
EPS Next 5YN/A
Revenue Next Year-33.12%
Revenue Next 2Y42.55%
Revenue Next 3Y72.08%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MYNA Yearly Revenue VS EstimatesMYNA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
MYNA Yearly EPS VS EstimatesMYNA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 -1 -2 -3

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MYNA. In the last year negative earnings were reported.
Also next year MYNA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MYNA Price Earnings VS Forward Price EarningsMYNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MYNA Per share dataMYNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3

4.3 Compensation for Growth

A more expensive valuation may be justified as MYNA's earnings are expected to grow with 18.85% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.74%
EPS Next 3Y18.85%

More info and screens

0

5. Dividend

5.1 Amount

MYNA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MYNARIC AG NA O.N.

NASDAQ:MYNA (2/14/2025, 8:00:00 PM)

After market: 0.2498 -0.01 (-4.95%)

0.2628

-0.16 (-38.02%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)10-03 2024-10-03
Earnings (Next)04-22 2025-04-22/amc
Inst Owners15.05%
Inst Owner Change-15.53%
Ins Owners3.58%
Ins Owner ChangeN/A
Market Cap6.64M
Analysts38
Price Target-1.64 (-724.05%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.91%
EPS NY rev (3m)-0.91%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.89%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.18
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4
EYN/A
EPS(NY)-3.01
Fwd EYN/A
FCF(TTM)-1.4
FCFYN/A
OCF(TTM)-1.2
OCFYN/A
SpS0.22
BVpS-2.04
TBVpS-2.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -78.54%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-70.83%
ROA(5y)-51.71%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 42.34%
Cap/Sales 91.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.74
Quick Ratio 0.44
Altman-Z -5.29
F-Score3
WACC17.03%
ROIC/WACCN/A
Cap/Depr(3y)142.1%
Cap/Depr(5y)386.08%
Cap/Sales(3y)270.71%
Cap/Sales(5y)968.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-34.86%
EPS Next Y11.27%
EPS Next 2Y15.74%
EPS Next 3Y18.85%
EPS Next 5YN/A
Revenue 1Y (TTM)21.89%
Revenue growth 3Y99.48%
Revenue growth 5Y31.63%
Sales Q2Q%-78.12%
Revenue Next Year-33.12%
Revenue Next 2Y42.55%
Revenue Next 3Y72.08%
Revenue Next 5YN/A
EBIT growth 1Y-4.98%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year29.67%
EBIT Next 3Y28.4%
EBIT Next 5YN/A
FCF growth 1Y44.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y42.28%
OCF growth 3YN/A
OCF growth 5YN/A